Alpad, Tolindon M.
HRN: 00-06-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2022
CEFTRIAXONE 1G (VIAL)
11/03/2022
11/09/2022
IV
2g
OD
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes